Cost-effectiveness of Intensive Blood Pressure Management-Is There an Additional Price to Pay?

JAMA Cardiol. 2017 May 1;2(5):581. doi: 10.1001/jamacardio.2016.5834.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antihypertensive Agents*
  • Blood Pressure / drug effects
  • Cost-Benefit Analysis
  • Humans
  • Hypertension*

Substances

  • Antihypertensive Agents